North Chicago Business
-
Abbott sues to block generic form of TriLipix as drug questionedMar 14, 2010 11:00 pm - Abbott Laboratories sued to prevent Impax Laboratories Inc. from selling a generic version of the cholesterol drug TriLipix until 2025. Impax said in a statement it is s...
-
Abbott to pay $450 million for Facet BiotechMar 09, 2010 10:00 pm - Abbott Laboratories, maker of the arthritis medicine Humira, succeeded in its bid for Facet Biotech Corp. by offering 54 percent more than Biogen Idec Inc. in its reject...
-
Abbott may be partner for Chi-MedMar 03, 2010 10:00 pm - Hutchison China MediTech Ltd., the pharmaceutical company controlled by Hong Kong billionaire Li Ka-shing, aims to find a partner this year for its experimental treatmen...
-
Abbott HIV drug being studied for possible heart harmFeb 22, 2010 10:00 pm - Two HIV drugs made by Abbott Laboratories and Roche Holding AG may be linked to heart-rhythm disorders when used together, U.S. regulators said, citing data gathered as ...
-
Convention center pondered for former Lakehurst mall siteJan 26, 2010 10:00 pm - Could the former Lakehurst Shopping Center site in Waukegan become the home of a $70 million convention center? The multipurpose center would host major conventions, tra...
-
Abbott profit little changed as costs offset salesJan 26, 2010 10:00 pm - NEW YORK -- Abbott Laboratories said Wednesday its fourth-quarter profit was flat on higher costs, but sales of the company's diverse mix of drugs, devices and nutrition...
-
Judge upholds Abbott's loss over glucose monitor claimJan 24, 2010 10:00 pm - Abbott Laboratories' loss in its bid to get more than $42 million from Becton, Dickinson & Co. and Nova Biomedical Corp. over a patent-infringement claim was upheld by a...
-
Abbott offers concessions in EU review of Solvay transactionJan 21, 2010 10:00 pm - Abbott Laboratories offered concessions to the European Union in a bid to win approval for its $6.8 billion purchase of Solvay SA's drug unit after regulators had concer...
-
Abbott partner Astellas rejected by top court on Omnicef patentJan 10, 2010 10:00 pm - The U.S. Supreme Court let stand a ruling permitting the sale of generic versions of Abbott Laboratories' Omnicef antibiotic, in a victory for Teva Pharmaceutical Indust...
-
Boston Scientific stent inferior to Abbott Lab's, study saysJan 07, 2010 10:00 pm - Boston Scientific Corp.'s Taxus Liberte stent shouldn't be used in routine clinical practice because it's inferior in terms of safety and efficacy to Abbott Laboratories...